S&P 500   4,351.24 (+0.49%)
DOW   34,108.94 (+0.11%)
QQQ   360.87 (+0.84%)
AAPL   176.19 (+1.30%)
MSFT   320.03 (+0.16%)
META   304.70 (+3.03%)
GOOGL   131.43 (+0.76%)
AMZN   131.31 (+1.53%)
TSLA   255.59 (-0.04%)
NVDA   418.77 (+2.10%)
NIO   8.60 (+1.78%)
BABA   88.16 (+4.82%)
AMD   97.89 (+1.85%)
T   15.16 (-0.98%)
F   12.57 (+3.03%)
MU   69.29 (+2.05%)
CGC   0.85 (+11.38%)
GE   112.90 (-0.08%)
DIS   82.22 (-0.62%)
AMC   7.85 (+1.95%)
PFE   32.69 (-0.49%)
PYPL   58.83 (+0.36%)
NFLX   384.02 (-0.03%)
S&P 500   4,351.24 (+0.49%)
DOW   34,108.94 (+0.11%)
QQQ   360.87 (+0.84%)
AAPL   176.19 (+1.30%)
MSFT   320.03 (+0.16%)
META   304.70 (+3.03%)
GOOGL   131.43 (+0.76%)
AMZN   131.31 (+1.53%)
TSLA   255.59 (-0.04%)
NVDA   418.77 (+2.10%)
NIO   8.60 (+1.78%)
BABA   88.16 (+4.82%)
AMD   97.89 (+1.85%)
T   15.16 (-0.98%)
F   12.57 (+3.03%)
MU   69.29 (+2.05%)
CGC   0.85 (+11.38%)
GE   112.90 (-0.08%)
DIS   82.22 (-0.62%)
AMC   7.85 (+1.95%)
PFE   32.69 (-0.49%)
PYPL   58.83 (+0.36%)
NFLX   384.02 (-0.03%)
S&P 500   4,351.24 (+0.49%)
DOW   34,108.94 (+0.11%)
QQQ   360.87 (+0.84%)
AAPL   176.19 (+1.30%)
MSFT   320.03 (+0.16%)
META   304.70 (+3.03%)
GOOGL   131.43 (+0.76%)
AMZN   131.31 (+1.53%)
TSLA   255.59 (-0.04%)
NVDA   418.77 (+2.10%)
NIO   8.60 (+1.78%)
BABA   88.16 (+4.82%)
AMD   97.89 (+1.85%)
T   15.16 (-0.98%)
F   12.57 (+3.03%)
MU   69.29 (+2.05%)
CGC   0.85 (+11.38%)
GE   112.90 (-0.08%)
DIS   82.22 (-0.62%)
AMC   7.85 (+1.95%)
PFE   32.69 (-0.49%)
PYPL   58.83 (+0.36%)
NFLX   384.02 (-0.03%)
S&P 500   4,351.24 (+0.49%)
DOW   34,108.94 (+0.11%)
QQQ   360.87 (+0.84%)
AAPL   176.19 (+1.30%)
MSFT   320.03 (+0.16%)
META   304.70 (+3.03%)
GOOGL   131.43 (+0.76%)
AMZN   131.31 (+1.53%)
TSLA   255.59 (-0.04%)
NVDA   418.77 (+2.10%)
NIO   8.60 (+1.78%)
BABA   88.16 (+4.82%)
AMD   97.89 (+1.85%)
T   15.16 (-0.98%)
F   12.57 (+3.03%)
MU   69.29 (+2.05%)
CGC   0.85 (+11.38%)
GE   112.90 (-0.08%)
DIS   82.22 (-0.62%)
AMC   7.85 (+1.95%)
PFE   32.69 (-0.49%)
PYPL   58.83 (+0.36%)
NFLX   384.02 (-0.03%)
NASDAQ:AWH

Aspira Women's Health (AWH) Stock Forecast, Price & News

$4.85
+0.28 (+6.13%)
(As of 10:31 AM ET)
Compare
Today's Range
$4.85
▼
$4.87
50-Day Range
$2.40
▼
$6.13
52-Week Range
$2.31
▼
$9.60
Volume
1,882 shs
Average Volume
40,467 shs
Market Capitalization
$49.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.80
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Aspira Women's Health MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
267.0% Upside
$17.80 Price Target
Short Interest
Healthy
2.12% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$580,110 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.98) to ($1.00) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.96 out of 5 stars

Medical Sector

565th out of 966 stocks

Diagnostic Substances Industry

8th out of 13 stocks

See Top Rated MarketRank™ Stocks Here

AWH stock logo

About Aspira Women's Health (NASDAQ:AWH) Stock

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering. Its product pipeline includes OvaWatch, a non-invasive blood-based risk assessment test to determine ovarian cancer risk for patients with an adnexal mass; and Endocheck, an in-development non-invasive blood test designed as an aid in the identification of endometriosis for patients with suspected endometriosis earlier in their prognosis journey. In addition, the company operates Aspira Synergy, a testing platform and cloud service; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas.

AWH Price History

AWH Stock News Headlines

September 15, 2023 | americanbankingnews.com
Aspira Women's Health (NASDAQ:AWH) and WuXi AppTec (OTCMKTS:WUXAY) Head to Head Analysis
September 14, 2023 | finance.yahoo.com
Is Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year?
September 22, 2023 | Legacy Research (Ad)
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing
In just a few days, the U.S. government could announce this mandatory recall on the U.S. dollar… And replace it with a new digital dollar. And that could send this $0.25 alternative investment skyrocketing.
September 13, 2023 | finance.yahoo.com
Aspira Women’s Health Regains Nasdaq Compliance
September 13, 2023 | finance.yahoo.com
Aspira Women’s Health Regains Nasdaq Compliance
September 12, 2023 | markets.businessinsider.com
Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer
September 11, 2023 | finance.yahoo.com
Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer
August 31, 2023 | msn.com
Aspira Women`s Health (AWH) Price Target Increased by 6.67% to 4.90
September 22, 2023 | Legacy Research (Ad)
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing
In just a few days, the U.S. government could announce this mandatory recall on the U.S. dollar… And replace it with a new digital dollar. And that could send this $0.25 alternative investment skyrocketing.
August 31, 2023 | marketwatch.com
Aspira Women's Health Shares Rise 10% After Sample-Procurement Deal
August 31, 2023 | finance.yahoo.com
Aspira Women’s Health Signs Exclusive Sample Procurement Agreement with The University of Oxford
August 29, 2023 | finance.yahoo.com
Aspira Women’s Health to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 28, 2023 | finance.yahoo.com
Aspira Women’s Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations
August 28, 2023 | finance.yahoo.com
Aspira Women’s Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations
August 24, 2023 | finance.yahoo.com
Aspira Womens Health Inc: A Deep Dive into Its Performance Potential
August 22, 2023 | msn.com
Alliance Global Partners Initiates Coverage of Aspira Women`s Health (AWH) with Buy Recommendation
August 15, 2023 | finanznachrichten.de
Aspira Women's Health Inc.: Aspira Women's Health Reports Second Quarter 2023 Financial Results
August 14, 2023 | finance.yahoo.com
Aspira Women’s Health® Reports Second Quarter 2023 Financial Results
August 11, 2023 | benzinga.com
Preview: Aspira Womens Health's Earnings
August 9, 2023 | finance.yahoo.com
Aspira Women’s Health Announces Transition of its Chief Scientific Officer/Chief Operating Officer
July 31, 2023 | finance.yahoo.com
Aspira Women’s Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 14, 2023
July 28, 2023 | finance.yahoo.com
An Insider Of Aspira Women's Health Picks Up 9.5% More Stock
July 23, 2023 | forbes.com
Women’s Health Ads Are Still Being Censored; The Center For Intimacy Justice Takes Action With FTC Complaint
July 20, 2023 | benzinga.com
Crude Oil Edges Higher; American Airlines Raises Profit Outlook
July 20, 2023 | benzinga.com
Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings
July 20, 2023 | marketwatch.com
Aspira Women's Health Shares Slide Premarket on Stock Sale >AWH
July 20, 2023 | finance.yahoo.com
Aspira Women’s Health Announces $4.7 Million Registered Direct Offering
See More Headlines
Receive AWH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aspira Women's Health and its competitors with MarketBeat's FREE daily newsletter.

AWH Company Calendar

Last Earnings
8/14/2023
Today
9/22/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AWH
CUSIP
N/A
CIK
926617
Web
www.aspirawh.com
Phone
512-519-0400
Fax
512-439-6908
Employees
85
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$17.80
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$5.60
Forecasted Upside/Downside
+289.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($12.4244)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-27,170,000.00
Net Margins
-199.77%
Pretax Margin
-199.77%
Return on Equity
-396.38%
Return on Assets
-119.23%

Debt

Debt-to-Equity Ratio
2.67
Current Ratio
1.28
Quick Ratio
1.23

Sales & Book Value

Annual Sales
$8.18 million
Price / Sales
5.70
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.81 per share
Price / Book
5.64

Miscellaneous

Outstanding Shares
10,200,000
Free Float
9,698,000
Market Cap
$46.61 million
Optionable
Optionable
Beta
2.80
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Ms. Nicole Sandford CPA (Age 53)
    Pres, CEO & Director
    Comp: $500.49k
  • Dr. Ryan Phan M.D. (Age 52)
    Ph.D., Chief Operating & Scientific Officer
    Comp: $453.7k
  • Ms. Minh Merchant (Age 50)
    Gen. Counsel & Corp. Sec.
    Comp: $325.92k
  • Dr. Torsten Hombeck Ph.D. (Age 53)
    Sr. VP & CFO
  • Ms. Michelle Snider
    Sr. VP of Commercial Strategy & Operations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













AWH Stock - Frequently Asked Questions

Should I buy or sell Aspira Women's Health stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aspira Women's Health in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" AWH shares.
View AWH analyst ratings or view top-rated stocks.

What is Aspira Women's Health's stock price forecast for 2023?

2 brokerages have issued twelve-month target prices for Aspira Women's Health's shares. Their AWH share price forecasts range from $5.60 to $30.00. On average, they predict the company's share price to reach $17.80 in the next twelve months. This suggests a possible upside of 289.5% from the stock's current price.
View analysts price targets for AWH or view top-rated stocks among Wall Street analysts.

How have AWH shares performed in 2023?

Aspira Women's Health's stock was trading at $4.9890 at the beginning of the year. Since then, AWH shares have decreased by 8.4% and is now trading at $4.57.
View the best growth stocks for 2023 here.

Are investors shorting Aspira Women's Health?

Aspira Women's Health saw a drop in short interest during the month of August. As of August 31st, there was short interest totaling 118,400 shares, a drop of 21.1% from the August 15th total of 150,100 shares. Based on an average trading volume of 61,800 shares, the days-to-cover ratio is presently 1.9 days. Currently, 2.1% of the company's shares are short sold.
View Aspira Women's Health's Short Interest.

When is Aspira Women's Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our AWH earnings forecast.

How were Aspira Women's Health's earnings last quarter?

Aspira Women's Health Inc. (NASDAQ:AWH) announced its earnings results on Monday, August, 14th. The company reported ($0.28) EPS for the quarter, beating analysts' consensus estimates of ($0.47) by $0.19. The firm earned $2.49 million during the quarter, compared to analyst estimates of $2.80 million. Aspira Women's Health had a negative net margin of 199.77% and a negative trailing twelve-month return on equity of 396.38%.

When did Aspira Women's Health's stock split?

Aspira Women's Health's stock reverse split on the morning of Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What is Scott A. Carmilani's approval rating as Aspira Women's Health's CEO?

33 employees have rated Aspira Women's Health Chief Executive Officer Scott A. Carmilani on Glassdoor.com. Scott A. Carmilani has an approval rating of 92% among the company's employees. This puts Scott A. Carmilani in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 97.0% of employees surveyed would recommend working at Aspira Women's Health to a friend.

What other stocks do shareholders of Aspira Women's Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aspira Women's Health investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and

What is Aspira Women's Health's stock symbol?

Aspira Women's Health trades on the NASDAQ under the ticker symbol "AWH."

Who are Aspira Women's Health's major shareholders?

Aspira Women's Health's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Portside Wealth Group LLC (1.83%), Portside Wealth Group LLC (2.24%), B. Riley Wealth Advisors Inc. (1.08%), BlackRock Inc. (0.79%), Geode Capital Management LLC (0.48%) and Quantum Private Wealth LLC (0.34%). Insiders that own company stock include Jack W Schuler, Nicole Sandford, Ryan Thinh Phan, Torsten Hombeck, Valerie Barber Palmieri and Veronica Gh Jordan.
View institutional ownership trends.

How do I buy shares of Aspira Women's Health?

Shares of AWH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aspira Women's Health's stock price today?

One share of AWH stock can currently be purchased for approximately $4.57.

How much money does Aspira Women's Health make?

Aspira Women's Health (NASDAQ:AWH) has a market capitalization of $46.61 million and generates $8.18 million in revenue each year. The company earns $-27,170,000.00 in net income (profit) each year or ($12.4244) on an earnings per share basis.

How can I contact Aspira Women's Health?

Aspira Women's Health's mailing address is 12117 BEE CAVES ROAD BUILDING THREE SUITE 100, AUSTIN TX, 78738. The official website for the company is www.aspirawh.com. The company can be reached via phone at 512-519-0400, via email at arr@lifesciadvisors.com, or via fax at 512-439-6908.

This page (NASDAQ:AWH) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -